AI assistant
Sending…
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021
Aug 30, 2021
29977_dirs_2021-08-30_62b1198a-313a-4785-8e66-7fa823c0248c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-08-26
Reporting Person: SING GEORGE L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-30 | Common Stock | S | 500 | $670.0 | Disposed | 43358 | Direct |
| 2021-08-30 | Common Stock | S | 500 | $675.0 | Disposed | 42858 | Direct |
| 2021-08-26 | Common Stock | S | 150 | $672.0 | Disposed | 1000 | Indirect |
| 2021-08-30 | Common Stock | S | 250 | $670.0 | Disposed | 750 | Indirect |
| 2021-08-30 | Common Stock | S | 300 | $672.0 | Disposed | 1750 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 400 | Indirect |
More from REGENERON PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 8
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3